Results 91 to 100 of about 10,335 (179)

Aptamer-liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives. [PDF]

Mater Today Bio
Gao Z, Du S, Song J, Gao Y, Peng X, Lin X, E S, Zhao Y, Zhang S.   +8 more
europepmc   +1 more source

AS1411 Aptamer-Conjugated Liposomal siRNA Targeting MTA2 Suppresses PI3K/AKT Signaling in Pancreatic Cancer Cells. [PDF]

Int J Mol Sci
Kwak M, Hua TC, Jin H, Lee J, Kim DE.
europepmc   +1 more source

Selective Delivery of Anticancer Natural G-Quadruplex Ligands by the AT11 Aptamer for Gastric Cancer Treatment. [PDF]

J Med Chem
Platella C, Trajkovski M, Brancaccio M, Di Palma R, Calcaterra A, Mori M, Falco G, Plavec J, Montesarchio D.   +8 more
europepmc   +1 more source

Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? [PDF]

Biomed Pharmacother
Tran TT, Tran VL, Fishel ML, Nguyen BT, Zhang J, Condello S, Zhong X, Schmidt M.   +7 more
europepmc   +1 more source

Correction: Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice. [PDF]

Med Microbiol Immunol
Hsiao NE, Wang YF, Lin YC, Chou WT, Hsu LJ, Wang SM, Wang JR, Lai MD, Chen SH, Chang CF.   +9 more
europepmc   +1 more source

A Modular DNAzyme for Precise Visualization and Intervention of Alternative Splicing Isoforms in Live Cells. [PDF]

Adv Sci (Weinh)
Lin M, Sun J, Mao Y, Tang Y, Wang F, Liu Z, Wang J.   +6 more
europepmc   +1 more source

CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer. [PDF]

Breast Cancer Res
Yan Y, Narayan A, Mazinani M, Saeki H, Huang T, Lofland G, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Sukumar S, Pomper MG, Merino VF.   +13 more
europepmc   +1 more source

Specificity of the stabilizing interaction between intrinsically disordered protein sequences and G-quadruplexes in RNA. [PDF]

Nucleic Acids Res
Cox LB, Mattick JS, Middleton IA, Rizzuto FJ, Thordarson P.   +4 more
europepmc   +1 more source

Ribosome biogenesis is increased in hepatocellular carcinoma and represents a potential therapeutic target. [PDF]

NAR Cancer
Geisler SB, Oxe KC, Boukoura S, Dulina E, Larsen DH.   +4 more
europepmc   +1 more source

Rewiring immunity: Midkine's emerging role in cancer immune escape and drug resistance. [PDF]

iScience
Saikia M, Prem S, Kapoor V.
europepmc   +1 more source